Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2005.248 | A Randomized, Open Label Study Evaluating the Efficacy and Safety of Peginterferon Alfa-2a (40KD) (PEGASYS_) or Adefovir Dipivoxil (ADV) in Patients with Lamivudine Resistant HBeAg Positive Chronic Hepatitis B | Prof. Sung JY Joseph |
2005.246 | The Use of Intravenous Ondansetron (Zofran_) to Relieve Postoperative Nausea and Vomiting after Intragastric Balloon Placement: A Randomized Controlled Trial | Dr. Mui Lik Man Wilfred |
2005.245 | A Multi-center Prospective Randomized Phase III Trial to Determine the Benefit of Adjuvant Chemotherapy Using Gemcitabine and Cisplatin in Nasopharyngeal Carcinoma Patients with Residual EBV DNA Following Primary Radiotherapy With or Without Concurrent Cisplatin | Prof. Chan T.C. Anthony |
2005.231 | Study of Pharmacogenetics, Pharmacodynamics and Population Pharmacokinetics of Rosuvastatin in Chinese Patients with Hyperlipidaemia | Prof. Brian Tomlinson |
2005.230 | Sensitivity of the InSync | Prof. Yu Cheuk Man |
2005.229 | A Phase I, Dose Escalation Trial of Recombinant Modified Vaccinia Ankara (MVA)-based Vaccine Encoding Epstein-Barr Virus Target Antigens | Prof. Chan T.C. Anthony |
2005.228 | A Triple-Blinded, Randomized, Placebo-Controlled Trial to Examine the Efficacy and Safety of ViNeuro in Patients with Parkinson | Dr. Yeung Hon Ming Jonas |
2005.224 | Outcome of Postnatal Depression Screening Using Edinburgh Postnatal Depression Scale | Prof. Lee T.S. Dominic |
2005.216 | A Phase III, Multicenter, Open-Label, Dose-Titrating, 16-week Study Evaluating the Efficacy, Tolerability and Safety of Olmesartan Medoxomil 20mg and 40mg Alone or in Combination with 12.5 mg to 25 mg of Hydrochlorothiazide in Subjects with Mild to Moderate Essential Hypertension | Prof. Lee Albert |
2005.212 | A Multicenter, Double-Blind, Randomized, Placebo Controlled Study on the Effect of Ultra-Low Dose Transdermal Estradiol (Menostar_ 0.014 mg/day via weekly patch) on the Incidence and Severity of Hot Flushes, Other Menopausal Symptoms and on Well-Being in Postmenopausal Asian Women Over 12 Weeks | Prof. Christopher John Haines |
2005.207 | Analgesic Efficacy and Pharmacokinetic of Ropivacaine Continuous Wound Instillation Following Hepatic Resection | Dr. Chan K.C. Simon |
2005.197 | An Open-Label Multicenter Randomized Phase 3 Study Comparing the Combination of DOXIL_/CAELYX_ and YONDELIS | Prof. Yeo Winnie |
2005.196 | An Expanded Access Program of Tarceva (Erlotinib) in Patients with Advanced Stage IIIB/IV Non-Small Cell Lung Cancer | Prof. Mok S.K. Tony |
2005.192 | The Efficacy of Imipramine in Treatment of Functional Dyspepsia: A Double Blind Randomized Placebo Controlled Trial | Dr. Wu Che Yuen Justin |
2005.189 | Randomized, Open-Label, Comparative Study To Evaluate Early Viral Load Reductions and Exploratory Viral Kinetics Following Administration of Entecavir or Adefovir in Nucleoside-Na_ve Adults with Chronic Hepatitis B Infection | Dr. Leung Wai Yee Nancy |
2005.186 | A Prospective Randomized Comparison of A Novel Hemostatic Clip (Resolution Clip | Dr. Wu Che Yuen Justin |
2005.184 | Effect of High Dose Intravenous and Oral Pantoprazole in Preventioin of Recurrent Bleeding from Peptic Ulcers after Endoscopic Therapy | Prof. Sung J.Y. Joseph |
2005.180 | A Pilot Study of Formula Pinggan in the Treatment of Liver Cirrhosis | Prof. Sung J.Y. Joseph |
2005.166 | A Twelve-week, Randomized, Double-blind, Parallel-group, Multicenter, Dose Escalation Study to Evaluate the Efficacy and Safety of Aliskiren Administered Alone and in Combination with Atenolol in Patients with Essential Hypertension | Prof. Yu Cheuk Man |
2005.157 | Endoluminal Implantation of Enteryx_ for the Treatment of Gastro-Esophageal Reflux Disease | Prof. Chiu Wai Yan Philip |
2005.156 | Clinical Bioequivalence Study on Two Allopurinol Formulations | Prof. Yin Qiping Ophelia |
2005.155 | Clinical Bioequivalence Study on Two Gliclazide Formulations | Prof. Chow S.S. Mossess |
2005.153 | A double-blind randomized comparison of celecoxib plus esomeprazole versus naproxen plus esomeprazole for prevention of recurrent ulcer bleeding in patients with arthritis and cardiothrombotic diseases (NSAID#8 Study) | Prof. CHAN Francis K. L. |
2005.151 | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of the Addition of MK-0431 to Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Glimepiride Alone or in Combination with Metformin | Dr. So Wing Yee |
2005.149 | A One-Year, Open-Label, Single Arm, Multi-Center Trial Evaluating the Efficacy and Safety of Oral ICL670 (20mg/kg/day) in Patients Diagnosed with Transfusion-dependent Iron Overload | Dr. Li Chi Kong |
2005.148 | Phase I Study on the Safety and Pharmacokinetics of IMD-1041 in Healthy Male Volunteers | Prof. Brian Tomlinson |
2005.146 | A Randomised, Double-Blind, Placebo-Controlled Study of Cilostazol 100mg Twice Daily in the Treatment of Diabetic Nephropathy in Hong Kong Chinese | Prof. Tong Chun Yip Peter |
2005.142 | Phase II Trial of PS-341 in Patients with Hepatocellular Carcinoma | Prof. Mok S.K. Tony |
2005.140 | Capsule Endoscopy or Mesenteric Angiogram in Patients with Overt Gastrointestinal Bleeding of Obscure Origin: A Randomized Study | Prof. Leung W.K. |
2005.139 | A 12-week, Double-Blind, Randomized Study to Investigate the Effect of 500_g Roflumilast Tablets Once Daily Versus Placebo on Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease | Prof. Hui Shu Cheong David |
2005.138 | International Diabetes Management Practices Study, The | Prof. Chan C.N. Juliana |
2005.137 | Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate Cancer | Dr. Ng Chi Fai |
2005.136 | A Single Arm Phase IV Study to Assess Efficacy and Safety of Bevacizumab in Combination With Irinotecan and Infusional 5 | Prof. Chan T.C. Anthony |
2005.133 | Follow-Up Serial Infusions of Natrecor_ (Nesiritide) for the Management of Patients with Heart Failure | Prof. Yu Cheuk Man |
2005.123 | Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen. A Novel Randomized Double-Blind Placebo-Control Clinical Trial in High-Risk Hypertensive Subjects | Prof. Chan Yan Keung Thomas |
2005.121 | Optimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies ptimisation of Antihypertensive Therapies: Application of Pharmacogenomic and Biochemical Technologies | Prof. Brian Tomlinson |
2005.120 | Comparison of Lercanidipine with Nifedipine Slow Release in Essential Hypertension | Prof. Brian Tomlinson |
2005.117 | A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Men With Premature Ejaculation | Dr. Ng Chi Fai |
2005.115 | Effects of Growth Hormone on Body Fat Distribution, Insulin Action and Cardiovascular Risk Factors in Middle-aged Men with Metabolic Syndrome | Prof. Kong PS Alice |
2005.114 | A Pilot Study of Enhanced External Counterpulsation for Cerebral Blood Flow Augmentation in Chinese Ischemic Stroke Patients with MCA Stenosis EASY-II | Prof. Wong Ka Sing Lawrence |
2005.111 | Prediction of Blood Pressure Response to Angiotensin Converting Enzyme Inhibitor or Angiotensin Receptor Blocker by Phenotypic and Genotypic Determinants in Chinese Patients with Type 2 Diabetes, Borderline Hypertension and Microalbuminuria | Prof. Brian Tomlinson |
2005.110 | A Randomized, Double-blind, Two-arms Placebo-controlled, Parallel-group, Multicenter Study of Rimonabant 20mg Once Daily in the Treatment of Atherogenic Dyslipidemia in Abdoninally Obese Patients | Prof. Brian Tomlinson |
2005.109 | An Open Label Trial of Telbivudine (LdT) in Adults with Chronic Hepatitis B Previously Treated in Idenix-Sponsored Telbivudine Studies | Dr. Leung WY Nancy |
2005.108 | A Multi-centre, Double-blinded, Randomized, Placebo-Controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome | Prof. Hui David |
2005.103 | Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven_/Niastase_) in Acute Intracerebral Haemorrhage (Trial Phase: 3a) | Prof. Wong Ka Sing Lawrence |
2005.095 | A Randomized, Open-labeled, Parallel, Comparative Study of the Efficacy and Tolerability of Rosuvastatin in LDL-C Reduction Using Different Dosing Regimes of 5mg Daily, 10mg Daily and 10mg Alternate day in Hong Kong Chinese Type 2 Diabetic Patients | Dr. Chow Chun Chung Francis |
2005.093 | A Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing with GW679769 (50mg or 150mg) for Three Consecutive Days When Administered with a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting and Post-discharge Nausea and Vomiting in Female Subjects with Known Risk Factors for Post-operative Nausea and Vomiting Who are Undergoing Laparoscopic/Laparotomic Surgical Procedures Associated with an Increased Emetogenic Risk | Prof. Gin Tony |
2005.087 | A Comparative Study of Visual Function Using the AcrySof Natural and the Acrysof SA 60 Intraocular Lens (IOLs) | Prof. Lam S.C. Dennis |
2005.084 | Clinical Study to Test the Efficacy of Herbal Medicine in Relieving Symptoms and Change of Quality of Life of Patients with IBS | Prof. Sung J.Y. Joseph |
2005.068 | A Six-Month Phase 3, Multicenter, Masked, Randomized, Sham-Controlled Trial (with Six-Month Open-Label Extension) to Assess the Safety and Efficacy of 700 | Prof. Lam S.C. Dennis |
Page 254 of 263.